Search Results - "Ghosh, Nilanjan"

CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s Lymphoma by Advani, Ranjana, Flinn, Ian, Popplewell, Leslie, Forero, Andres, Bartlett, Nancy L, Ghosh, Nilanjan, Kline, Justin, Roschewski, Mark, LaCasce, Ann, Collins, Graham P, Tran, Thu, Lynn, Judith, Chen, James Y, Volkmer, Jens-Peter, Agoram, Balaji, Huang, Jie, Majeti, Ravindra, Weissman, Irving L, Takimoto, Chris H, Chao, Mark P, Smith, Sonali M

“…An antibody to CD47 used in combination with rituximab induced responses in half of a small group of patients with refractory B-cell lymphoma. Inhibiting the…”
Get full text

Between Growth-fetishism and Green Recovery by Ghosh, Nilanjan

“…This paper posits that the choices that global economies are faced with for post-pandemic development range between the extremes of growth-fetishism and green…”
Get full text

Molecular mechanism of diabetic cardiomyopathy and modulation of microRNA function by synthetic oligonucleotides by Ghosh, Nilanjan, Katare, Rajesh

“…Diabetic cardiomyopathy (DCM) is a chronic complication in individuals with diabetes and is characterized by ventricular dilation and hypertrophy, diastolic…”
Get full text

Novel and multiple targets for chimeric antigen receptor-based therapies in lymphoma by Pang, Yifan, Ghosh, Nilanjan

“…Chimeric antigen receptor (CAR) T-cell therapy targeting CD19 in B-cell non-Hodgkin lymphoma (NHL) validates the utility of CAR-based therapy for lymphomatous…”
Get full text

Ibrutinib plus lenalidomide and rituximab has promising activity in relapsed/refractory non–germinal center B-cell–like DLBCL by Goy, Andre, Ramchandren, Radhakrishnan, Ghosh, Nilanjan, Munoz, Javier, Morgan, David S., Dang, Nam H., Knapp, Mark, Delioukina, Maria, Kingsley, Edwin, Ping, Jerry, Beaupre, Darrin M., Neuenburg, Jutta K., Ruan, Jia

“…The outcome of patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL) is poor, particularly in patients ineligible for stem cell…”
Get full text

Targeting mangiferin loaded N-succinyl chitosan-alginate grafted nanoparticles against atherosclerosis – A case study against diabetes mediated hyperlipidemia in rat by Wang, Ying, Karmakar, Tanushree, Ghosh, Nilanjan, Basak, Souvik, Gopal Sahoo, Nanda

“…[Display omitted] •N-succinylated chitosan (NCS), mangiferin (MGF) are conjugated into a nanohybrid.•The NCS-MGF conjugate particle size is measured as 100 ∼…”
Get full text

Lymphoma by Mugnaini, Emiliano N., MD, PhD, Ghosh, Nilanjan, MD, PhD

“…Lymphomas may be broadly divided into non-Hodgkin (90%) and Hodgkin (10%) types. Most lymphomas (90%) are of B cell origin but can also be T cell or natural…”
Get full text

Reduced-Intensity Transplantation for Lymphomas Using Haploidentical Related Donors Versus HLA-Matched Sibling Donors: A Center for International Blood and Marrow Transplant Research Analysis by Ghosh, Nilanjan, Karmali, Reem, Rocha, Vanderson, Ahn, Kwang Woo, DiGilio, Alyssa, Hari, Parameswaran N, Bachanova, Veronika, Bacher, Ulrike, Dahi, Parastoo, de Lima, Marcos, D'Souza, Anita, Fenske, Timothy S, Ganguly, Siddhartha, Kharfan-Dabaja, Mohamed A, Prestidge, Tim D, Savani, Bipin N, Smith, Sonali M, Sureda, Anna M, Waller, Edmund K, Jaglowski, Samantha, Herrera, Alex F, Armand, Philippe, Salit, Rachel B, Wagner-Johnston, Nina D, Fuchs, Ephraim, Bolaños-Meade, Javier, Hamadani, Mehdi

“…Related donor haploidentical hematopoietic cell transplantation (Haplo-HCT) using post-transplantation cyclophosphamide (PT-Cy) is increasingly used in…”
Get full text

Exercise Regulates MicroRNAs to Preserve Coronary and Cardiac Function in the Diabetic Heart by Lew, Jason Kar-Sheng, Pearson, James T., Saw, Eugene, Tsuchimochi, Hirotsugu, Wei, Melanie, Ghosh, Nilanjan, Du, Cheng-Kun, Zhan, Dong-Yun, Jin, Meihua, Umetani, Keiji, Shirai, Mikiyasu, Katare, Rajesh, Schwenke, Daryl O.

“…Diabetic heart disease (DHD) is a debilitating manifestation of type 2 diabetes mellitus. Exercise has been proposed as a potential therapy for DHD, although…”
Get full text

PD-L1 Status in Refractory Lymphomas by Vranic, Semir, Ghosh, Nilanjan, Kimbrough, Jeffery, Bilalovic, Nurija, Bender, Ryan, Arguello, David, Veloso, Yvonne, Dizdarevic, Aida, Gatalica, Zoran

“…Targeted immunotherapy based on PD-1/PD-L1 suppression has revolutionized the treatment of various solid tumors. A remarkable improvement has also been…”
Get full text

Antioxidant protection: A promising therapeutic intervention in neurodegenerative disease by Ghosh, Nilanjan, Ghosh, Rituparna, Mandal, Subhash C

“…Oxidative stress has been consistently linked to ageing-related neurodegenerative diseases. Neurodegenerative diseases are characterized by progressive…”
Get more information

Allogeneic transplant following CAR T-cell therapy for large B-cell lymphoma by Zurko, Joanna, Ramdial, Jeremy, Shadman, Mazyar, Ahmed, Sairah, Szabo, Aniko, Iovino, Lorenzo, Tomas, Ana Alarcon, Sauter, Craig, Perales, Miguel-Angel, Shah, Nirav N, Acharya, Utkarsh H, Jacobson, Caron, Soiffer, Robert J, Wang, Trent, Komanduri, Krishna V, Jaglowski, Samantha, Kittai, Adam S, Denlinger, Nathan, Iqbal, Madiha, Kharfan-Dabaja, Mohamed A, Ayala, Ernesto, Chavez, Julio, Jain, Michael, Locke, Frederick L, Samara, Yazeed, Budde, Lihua E, Mei, Matthew G, Pia, Alexandra Della, Feldman, Tatyana, Ahmed, Nausheen, Jacobs, Ryan, Ghosh, Nilanjan, Dholaria, Bhagirathbhai, Oluwole, Olalekan O, Hess, Brian, Hassan, Ayesha, Kenkre, Vaishalee P, Reagan, Patrick, Awan, Farrukh, Nieto, Yago, Hamadani, Mehdi, Herrera, Alex F

“…Allogeneic hematopoietic cell transplantation (alloHCT) can potentially salvage large B-cell lymphoma (LBCL) patients experiencing treatment failure after…”
Get full text

Obstacles to global implementation of CAR T cell therapy in myeloma and lymphoma by Medina-Olivares, Fernando J, Gómez-De León, Andrés, Ghosh, Nilanjan

“…Chimeric Antigen Receptor T-cell (CAR-T) therapies are transforming the treatment of B-cell lymphoproliferative disorders and multiple myeloma, yet global…”
Get full text

Comparative efficacy of lisocabtagene maraleucel in the PILOT study versus second-line chemotherapy regimens in the real world by Ghosh, Nilanjan, Sehgal, Alison, Liu, Fei Fei, Kostic, Ana, Crotta, Alessandro, De Benedetti, Marc, Faccone, Jillian, Peng, Lily, Gordon, Leo I

“…This study assessed the comparative efficacy of lisocabtagene maraleucel (liso-cel) in PILOT (NCT03483103), an open-label, phase II study, versus conventional…”
Get full text

Lisocabtagene maraleucel for second-line relapsed or refractory large B-cell lymphoma: patient-reported outcomes from the PILOT study by Gordon, Leo I, Liu, Fei Fei, Braverman, Julia, Hoda, Daanish, Ghosh, Nilanjan, Hamadani, Mehdi, Hildebrandt, Gerhard C, Peng, Lily, Guo, Shien, Shi, Ling, Sehgal, Alison

“…In the single-arm, open-label, multicenter, phase II PILOT study, second-line treatment with the chimeric antigen receptor (CAR) T-cell therapy lisocabtagene…”
Get full text

Cardiovascular Complications in Patients with Kawasaki Disease in a Tertiary Care Hospital in West Bengal, Eastern India- A Prospective Clinical Study by Sayani Pan, Uttam Kumar Roy, Nilanjan Ghosh, Tarak Nath Ghosh

“…Introduction: Kawasaki Disease (KD) is an acute self-limiting systemic vasculitis involving medium and small-sized arteries. It may soon replace rheumatic…”
Get full text

In Silico Modeling and Structural Analysis of Soluble Epoxide Hydrolase Inhibitors for Enhanced Therapeutic Design by Sar, Shuvam, Mitra, Soumya, Panda, Parthasarathi, Mandal, Subhash C, Ghosh, Nilanjan, Halder, Amit Kumar, Cordeiro, Maria Natalia D. S

“…Human soluble epoxide hydrolase (sEH), a dual-functioning homodimeric enzyme with hydrolase and phosphatase activities, is known for its pivotal role in the…”
Get full text

ASTCT, CIBMTR, and EBMT clinical practice recommendations for transplant and cellular therapies in mantle cell lymphoma by Munshi, Pashna N., Hamadani, Mehdi, Kumar, Ambuj, Dreger, Peter, Friedberg, Jonathan W., Dreyling, Martin, Kahl, Brad, Jerkeman, Mats, Kharfan-Dabaja, Mohamed A., Locke, Frederick L., Shadman, Mazyar, Hill, Brian T., Ahmed, Sairah, Herrera, Alex F., Sauter, Craig S., Bachanova, Veronika, Ghosh, Nilanjan, Lunning, Matthew, Kenkre, Vaishalee P., Aljurf, Mahmoud, Wang, Michael, Maddocks, Kami J., Leonard, John P., Kamdar, Manali, Phillips, Tycel, Cashen, Amanda F., Inwards, David J., Sureda, Anna, Cohen, Jonathon B., Smith, Sonali M., Carlo-Stella, Carmello, Savani, Bipin, Robinson, Stephen P., Fenske, Timothy S.

“…Autologous (auto-) or allogeneic (allo-) hematopoietic cell transplantation (HCT) are accepted treatment modalities for mantle cell lymphoma (MCL). Recently,…”
Get full text

Amino acids with an intermolecular proton bond as proton storage site in bacteriorhodopsin by Phatak, Prasad, Ghosh, Nilanjan, Yu, Haibo, Cui, Qiang, Elstner, Marcus

“…The positions of protons are not available in most high-resolution structural data of biomolecules, thus the identity of proton storage sites in biomolecules…”
Get full text

Obinutuzumab-atezolizumab-lenalidomide for the treatment of patients with relapsed/refractory follicular lymphoma: final analysis of a Phase Ib/II trial by Morschhauser, Franck, Ghosh, Nilanjan, Lossos, Izidore S., Palomba, M. Lia, Mehta, Amitkumar, Casasnovas, Olivier, Stevens, Don, Katakam, Sudhakar, Knapp, Andrea, Nielsen, Tina, McCord, Ron, Salles, Gilles

“…We evaluated the triplet regimen obinutuzumab-atezolizumab-lenalidomide (G-atezo-len) for patients with relapsed/refractory (R/R) follicular lymphoma (FL) in…”
Get full text